Guanine-Based RNA Tetrads Turn on Stress Granules, Rescue Neurons
Researchers mimic neuroprotective RNAs with stable DNAs that can do the same job.
6400 RESULTS
Sort By:
Researchers mimic neuroprotective RNAs with stable DNAs that can do the same job.
Posing as the amino acid tyrosine, the anti-aging compound resveratrol turns on a new target, PARP1.
Alzforum looks back on last year's research newsmakers.
Measuring total prion protein in cerebrospinal fluid could help clinicians differentiate between prion disease and rapidly progressing forms of dementia.
Like a second skin, a new kind of neural implant is as compliant as the protective dura membrane that envelops the central nervous system.
Sil1’s presence keeps the endoplasmic reticulum from activating a chronic stress response.
A study reports a high incidence of criminal behavior in people with frontotemporal dementia. Especially for the undiagnosed, real trouble lies ahead.
Three new therapies enhance the therapeutic effects of levodopa.
Partnership will sequence the entire genomes of 3,000 patients.
Cross-sectional biomarker data from the Colombian kindred confirm models of biomarker progression, but suggest an earlier drop in brain metabolism.
Using baseline brain scans, the model projects where atrophy will occur and metabolism will wane.
Both motor neurons in the brain and neuromuscular junctions in the periphery exhibit defects in young ALS mouse models.
Irritability and depression emerge sooner in AD than in the general population.
Neurons derived from stem cells of people with amyotrophic lateral sclerosis bungle the transmission of electrical signals.
The addition of a sugar to β-secretase ramps up Aβ production. Could reducing that sweet addition slow progression of Alzheimer's?